Stem cells and lung cancer: Future therapeutic targets?

Expert Opinion on Biological Therapy

Volumn 9, Issue 9, 2009, Pages 1127-1141

  Alison, Malcolm R ^a,b   Lebrenne, Arielle C ^a,b   Islam, Shahriar ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ICMS   (United Kingdom)

Author keywords

ALDH; Bronchioalveolar duct junction (BADJ); CD133; Drug resistance; EMT; Lung cancer; SP; Stem cells

Indexed keywords

ABC TRANSPORTER; BETA1 INTEGRIN; MULTIDRUG RESISTANCE PROTEIN 1; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; TRANSCRIPTION FACTOR NANOG; TUBERIN;

ADULT STEM CELL; CANCER MORTALITY; CANCER RESISTANCE; CANCER STEM CELL; CAUSE OF DEATH; CELL ISOLATION; CELL TYPE; COLONY FORMING UNIT; HISTOGENESIS; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RESPIRATORY SYSTEM; REVIEW; TUMOR GROWTH; UNITED KINGDOM; UNITED STATES;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DISEASE MODELS, ANIMAL; HUMANS; LUNG; LUNG NEOPLASMS; STEM CELLS;

ANIMALIA;

EID: 68949162118     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590903103803     Document Type: Review

References (127)

1. Cancerstats. London: Cancer research UK 2009. Available from: http://info.cancerresearchuk.org/cancerstats/ [Last accessed 22 June 2009]
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics. CA Cancer J Clin 2002;55:43-66
3. Barker N, Ridgway RA, van Es JH et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608-611
4. Alison MR, Islam S. Attributes of adult stem cells. J Pathol 2009;127:144-160
5. Webb A, Li A, Kaur P. Location and phenotype of human adult keratinocyte stem cells of the skin. Differentiation 2004;72:387-395 (Pubitemid 41702116)
6. Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 1993;73:713-724 (Pubitemid 23159010)
7. Shackleton M, Vaillant F, Simpson KJ, et al. Generation of a functional mammary gland from a single stem cell. Nature 2006;439:84-88 (Pubitemid 43053633)
8. Stingl J, Eirew P, Ricketson I, et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006;439:993-997 (Pubitemid 43292419)
9. Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating invivo. J Exp Med 1996;183:1797-1806 (Pubitemid 26134320)
10. Zhou S, Morris JJ, Barnes Y, et al. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA 2002;99:12339-12344
11. Guo Y, Lubbert M, Engelhardt M. CD34- Hematopoietic stem cells: current concepts and controversies. Stem Cells 2003;21:15-20 (Pubitemid 36120361)
12. Krishnamurthy P, Schuetz JD. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol 2006;46:381-410
13. Atp Binding Cassette Transporters. Micael Müller, 1996. Available from: http://www.nutrigene.4t.com/humanabc.htm [Last accessed 23 June 2009]
14. Available from: http://ssrl.slac.stanford.edu/research/highlights- archive/rees-abc.html
15. Türk D, Szakács G. Relevance of multidrug resistance in the age of targeted therapy. Curr Opin Drug Discov Devel 2009;12:246-252
16. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy. Cell Cycle 2005;4:203-205
17. Alison MR. Tissue-based stem cells: ABC transporter proteins take centre stage. J Pathol 2003;200:547-550
18. Teramura T, Fukuda K, Kurashimo S, et al. Isolation and characterization of side population stem cells in articular synovial tissue. BMC Musculoskelet Disord 2008;9:86. Published online 12 June 2008, doi:10.1186/1471-2474-9-86 (Pubitemid 351904888)
19. Douville J, Beaulieu R, Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 2009;18:17-26
20. Corti S, Locatelli F, Papadimitriou D, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006;24:975-985 (Pubitemid 44464730)
21. Mirabelli P, Di Noto R, Lo Pardo C, et al. Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studies. BMC Physiol 2008;8:13. Published online 29 May 2008, doi:10.1186/1472-6793-8-13 (Pubitemid 351814581)
22. Dylla SJ, Beviglia L, Park IK, et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS ONE 20083:e2428. Published online 18 June 2008, doi:10.1371/journal.pone.0002428
23. Giangreco A, Shen H, Reynolds SD, et al. Molecular phenotype of airway side population cells. Am J Physiol Lung Cell Mol Physiol 2004;286:L624-30 (Pubitemid 38365044)
24. Park IK, Morrison SJ, Clarke MF. Bmi1, stem cells, and senescence regulation.J Clin Invest 2004;113:175-179
25. Molofsky AV, Pardal R, Iwashita T, et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003;425:962-967 (Pubitemid 37376927)
26. Arf senescence pathways. Genes Dev 2005;19:1432-1437
27. Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. J Pathol 2008;214:3-9
28. Alison MR, Murphy G, Leedham S. Stem cells and cancer: a deadly mix.Cell Tissue Res 2008;331:109-124
29. Bauer N, Fonseca AV, Florek M, et al. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs 2008;188:127-138 (Pubitemid 351962236)
30. Burkert J, Wright NA, Alison MR. Stem cells and cancer: an intimate relationship.J Pathol 2006;209:287-297
31. - metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-2120
32. Borthwick DW, Shahbazian M, Krantz QT, et al. Evidence for stem-cell niches in the tracheal epithelium.Am J Respir Cell Mol Biol 2001;24:662-670
33. Daniely Y, Liao G, Dixon D, et al. Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. Am J Physiol Cell Physiol 2004;287:C171-81 (Pubitemid 38780165)
34. Hong KU, Reynolds SD, Watkins S, et al. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 2004;164:577-588 (Pubitemid 38364673)
35. Reynolds SD, Giangreco A, Power JHT, et al. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 2000;156:269-278 (Pubitemid 30644460)
36. Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 2002;161:173-182 (Pubitemid 34760783)
37. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-835 (Pubitemid 40806415)
38. Giangreco A, Groot KR, Janes SM. Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med 2007;175:547-553
39. Riely GJ, Marks J, Pao W. KRAS mutations in non-small cell lung cancer. Proc Am Thorac Soc 2009;6:201-205
40. Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001;15:3243-3248 (Pubitemid 34008190)
41. Franklin WA, Gazdar AF, Haney J, et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997;100;2133-2137 (Pubitemid 27459370)
42. Meuwissen R, Linn SC, Linnoila RI, et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 2003;4:181-189 (Pubitemid 37163832)
43. Watkins DN, Berman DM, Burkholder SG, et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003;422:313-317
44. Collins BJ, Kleeberger W, Ball DW. Notch in lung development and lung cancer. Semin Cancer Biol 2004;14:357-364
45. Koch LK, Zhou H, Ellinger J, et al. Stem cell marker expression in small cell lung carcinoma and developing lung tissue. Hum Pathol 2008;39:1597-1605
46. Dacic S. Pulmonary preneoplasia. Arch Pathol Lab Med 2008;132:1073-1078
47. Wang Y, Zhang Z, Yan T, et al. A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility. Cancer Res 2004;64:1647-1654 (Pubitemid 38428685)
48. Barth PJ, Koch S, Müller B, et al. Proliferation and number of Clara cell 10-kDa protein (CC10)-reactive epithelial cells and basal cells in normal, hyperplastic and metaplastic bronchial mucosa. Virchows Arch 2000;437:648-655 (Pubitemid 32003096)
49. Ji H, Ramsey MR, Hayes DN, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007;448:807-810 (Pubitemid 47266337)
50. Kim CF. Paving the road for lung stem cell biology: bronchioalveolar stem cells and other putative distal lung stem cells. Am J Physiol Lung Cell Mol Physiol 2007;293:L1092-8
51. Politi K, Zakowski MF, Fan PD, et al. Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes Dev 2006;20:1496-1510 (Pubitemid 43830656)
52. Dovey JS, Zacharek SJ, Kim CF, et al. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci USA 2008;105:11857-11862 • This research demonstrated that Bmi1 is required for continued proliferation/expansion of the BADJ-located putative founder cells of mutant K-ras initiated adenocarcinomas in the mouse.
53. Liu Y, Martinez L, Ebine K, et al. Role for mitogen-activated protein kinase p38α in lung epithelial branching morphogenesis. Dev Biol 2008;314:224-235
54. Ventura JJ, Tenbaum S, Perdiguero E, et al. p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 2007;39:750-758 •• This paper describes the key role of p38α in promoting cell differentiation, negatively regulating stem cell proliferation. Loss of p38α sensitizes mice to mutated K-ras tumorigenesis. However, it should be noted that the inducible Cre-ERT2 recombinase was under the control of the locus encoding the large subunit of RNA polymerase II, thus deletion of MAPK14 was not specific to BASCs, and lung tumour susceptibility may have been indirectly influenced by MAPK14 deletion in other tissues.
55. Kip1 function in tumorigenesis. Genes Dev 2007;21:1703-1706
56. Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers. Cancer Res 2007;67:3162-3170
57. Hui L, Bakiri L, Mairhorfer A, et al. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 2007;39:741-749 (Pubitemid 46848584)
58. Yang Y, Iwanaga K, Gabriela Raso M, et al. Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer. PLoS ONE 20083:e2220. Published online 21 May 2008, doi:10.1371/journal.pone.0002220 • This paper describes the significance of an intact PI3K-Akt-mTOR pathway for stem cell expansion and mutated K-ras tumorigenesis, underscoring the significance of Pten loss in lung tumorigenesis.
59. Yanagi S, Kishimoto H, Kawahara K, et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest 2007;117:2929-2940 (Pubitemid 47529623)
60. Hill R, Wu H. PTEN, stem cells, and cancer stem cells. J Biol Chem 2009;284:11755-11759
61. Zheng H, Ying H, Yan H, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 2008;455:1129-1133
62. Qian S, Ding JY, Xie R, et al. MicroRNA expression profile of bronchioalveolar stem cells from mouse lung. Biochem Biophys Res Commun 2008;377:668-673
63. Yang P, Sun Z, Krowka MJ, et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 2008;168:1097-1103 (Pubitemid 351749227)
64. Makowski L, Hayes DN. Role of LKB1 in lung cancer development. Br J Cancer 2008;99:683-688
65. Mori M, Rao SK, Popper HH, et al. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung. Mod Pathol 2001;14:72-84 (Pubitemid 32173389)
66. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-1075 • A large collaborative study of gene mutations in almost 200 human lung adenocarcinomas, with correlations made with clinical features, smoking status and DNA repair defects.
67. Yoshida Y, Shibata T, Kokubu A, et al. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 2005;50:1-8 (Pubitemid 41297463)
68. Kanomata N, Nakahara R, Oda T, et al. Expression and localization of mRNAs for matrix metalloproteinases and their inhibitors in mixed bronchioloalveolar carcinomas with invasive components. Mod Pathol 2005;18:828-837 (Pubitemid 40780517)
69. Alison MR, Lim S, Houghton JM. Bone marrow-derived cells and epithelial tumours: more than just an inflammatory relationship. Curr Opin Oncol 2009;21:77-82
70. Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999;18:643-650 (Pubitemid 29080321)
71. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002;64:681-708
72. Kaye FJ. Defining a candidate lung cancer gene. J Natl Cancer Inst 2008;100;1564-1565
73. Soh J, Toyooka S, Ichihara S, et al. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung. J Thorac Oncol 2008;3:340-347
74. Sekido Y, Fong KM, Minna JD. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1998;1378:F21-59 (Pubitemid 28381125)
75. Panani AD, Roussos C. Cytogenetic and molecular aspects of lung cancer. Cancer Lett 2006;239:1-9 (Pubitemid 43964875)
76. Liu H, Kho AT, Kohane IS, et al. Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development. PLoS Med 2006;3:e232. Published online 4 July 2006, doi:10.1371/journal.pmed.0030232 (Pubitemid 44125995)
77. Damiani LA, Yingling CM, Leng S, et al. Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells. Cancer Res 2008;68:9005-9014 • This paper highlights the significance of promoter shutdown, by hypermethylation, of cell-cell adhesion genes in neoplastic progression.
78. Reamon-Buettner SM, Borlak J. Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors. Cancer Res 2008;68:7587-7596
79. Kuramochi M, Fukuhara H, Nobukuni T, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.Nat Genet 2001;27:427-430
80. Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008;359:2143-2153
81. Ohta T, Iijima K, Miyamoto M, et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 2008;68:1303-1309 (Pubitemid 351346836)
82. Boggaram V. Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung. Clin Sci (Lond) 2009;116:27-35
83. Anagnostu VK, Syrigos KN, Bepler G, et al. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage 1 lung adenocarcinoma. J Clin Oncol 2009;27:271-278
84. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-1406
85. Tiberio C, Barba P, Magli MC, et al. Hox gene expression in human small-cell lung cancers xenografted into nude mice. Int J Cancer 1994;58:608-615 (Pubitemid 24268107)
86. Lechner JF, Wang Y, Siddiq F, et al. Human lung cancer cells and tissues partially recapitulate the homeobox gene expression profile of embryonic lung. Lung Cancer 2002;37:41-47 (Pubitemid 34621457)
87. Hougaard S, Nørgaard P, Abrahamsen N, et al. Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines. Br J Cancer 1999;79:1005-1011 (Pubitemid 29087867)
88. Zhang HT, Chen XF, Wang MH, et al. Defective expression of transforming growth factor β receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer.Clin Cancer Res 2004;10:2359-2367
89. You L, He B, Xu Z, et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004;23:6170-6174 (Pubitemid 39178870)
90. Sunaga N, Kohno T, Kolligs FT, et al. Constitutive activation of the Wnt signaling pathway by CTNNB1 (β-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 2001;30:316-321 (Pubitemid 32126211)
91. Kelly PN, Dakic A, Adams JM, et al. Tumor growth need not be driven by rare cancer stem cells. Science 2007;317:337
92. Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature 2008;451:345-349
93. Quintana E, Shackleton M, Sabel MS, et al. Efficient tumour formation by single human melanoma cells. Nature 2008;456:593-598 •• A clear demonstration that the assay for human CSCs, or more correctly, TICs, in the NOD/SCID mouse probably seriously inderestimates the frequency of CSCs, at least for malignant melanoma. The authors used more highly immunocompromised mice and mixed the cells with Matrigel.
94. Yoo MH, Hatfield DL. The cancer stem cell theory: Is it correct? Mol Cells 2008;26:1-10
95. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-715 (Pubitemid 351636299)
96. Brabletz S, Schmalhofer O, Brabletz T. Gastrointestinal stem cells in development and cancer. J Pathol 2009;217:307-317
97. Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-323 (Pubitemid 47355323)
98. Tesei A, Zoli W, Arienti C, et al. Isolation of stem/progenitor cells from normal lung tissue of adult humans. Cell Prolif 2009;42:298-308
99. Wang SP, Wang WL, Chang YL, et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 2009;11:694-704 •• This research demonstrated, as expected, that NSCLC patients with wild-type p53 had high levels of the ubiquitin ligase MDM2, and that MDM2 is responsible for the ubiquitination and subsequent proteasomal degradation of Slug. In patients with mutant p53, there was no expression of MDM2, so Slug was upregulated and consequently E-cadherin was not expressed; this resulted in more invasive tumours through EMT. This paper highlights the role of p53 in tumour invasion, extending its repertoire beyond apoptosis and cell cycle arrest.
100. Kirkland SC. Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium. Cancer 1988;61:1359-1363
101. Vermeulen L, Todaro M, de Sousa Mello F, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 2008;105:13427-13432
102. Carney DN, Gazdar AF, Bunn PA Jr, et al. Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. Stem Cells 1982;1:149-164
103. - subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci 2009;100:1040-1046
104. Chen YC, Hsu HS, Chen YW, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 2008;3:e2637. Published online 9 July 2008, doi:10.1371/journal.pone.0002637
105. Karoubi G, Gugger M, Schmid R, et al. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention. Interact Cardiovasc Thorac Surg 2009;4:393-397
106. Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008;15:504-514 (Pubitemid 351267301)
107. Levina V, Marrangoni AM, Demarco R, et al. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS ONE 2008;3(8):e3077. Published online 27 August 2008, doi: 10.1371/journal. pone.0003077
108. Sung JM, Cho HJ, Yi H, et al. Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun 2008;371:163-167
109. Das B, Tsuchida R, Malkin D, et al. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 2008;26:1818-1830
110. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009;7:330-338
111. Jiang T, Collins BJ, Jin N, et al. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res 2009;69:845-854
112. Gutova M, Najbauer J, Gevorgyan A, et al. Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS ONE 2007;2:e243. published online 28 February 2007, doi:10.1371/journal.pone.0000243
113. Peacock CD, Watkins DN. Cancer stem cells and the ontogeny of lung cancer. J Clin Oncol 2008;26:2883-2889
114. Daniel VC, Peacock CD, Watkins DN. Developmental signalling pathways in lung cancer. Respirology 2006;11:234-240
115. Koch LK, Zhou H, Ellinger J, et al. Stem cell marker expression in small cell lung carcinoma and developing lung tissue. Hum Pathol 2008;39:1597-1605
116. Yu Q, Su B, Liu D, et al. Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549. Oligonucleotides 2007;17:327-335 (Pubitemid 47463364)
117. Grosveld GC. γ-secretase inhibitors: Notch so bad. Nat Med 2009;15:20-21
118. Marinov M, Ziogas A, Pardo OE, et al. AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001. Clin Cancer Res 2009;15:1277-1287
119. Hambardzumyan D, Becher OJ, Rosenblum MK, et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma invivo. Genes Dev 2008;22:436-448 (Pubitemid 351272752)
120. Subramanian J, Govindan R. Small cell, big problem! Stem cells, root cause? Clin Lung Cancer 2008;9:252-253
121. Iwasa T, Okamoto I, Suzuki M, et al. Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines. Clin Cancer Res 2008;14:6496-6504
122. Vogler M, Dinsdale D, Dyer MJ, et al. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 2009;16:360-367
123. Hou S, Zhao Z, Yan F, et al. Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer. Cell Biol Int 2009;33:276-282
124. Hu T, Liu S, Breiter DR, et al. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 2008;68:6533-6540
125. Liang Y. An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med Genomics 2008;1:61. Published online 16 December 2008, doi:10.1186/1755-8794-1-61
126. Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 2008;15:739-752 (Pubitemid 351627357)
127. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008;372:2023-2030